Bio Works (Sweden) Performance
| BIOWKS Stock | SEK 2.10 0.10 5.00% |
On a scale of 0 to 100, Bio Works holds a performance score of 15. The firm shows a Beta (market volatility) of 0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bio Works' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Works is expected to be smaller as well. Please check Bio Works' semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Bio Works' price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Works Technologies AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Bio Works sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 33.1 M | |
| Total Cashflows From Investing Activities | -942 K |
Bio |
Bio Works Relative Risk vs. Return Landscape
If you would invest 128.00 in Bio Works Technologies AB on April 27, 2025 and sell it today you would earn a total of 82.00 from holding Bio Works Technologies AB or generate 64.06% return on investment over 90 days. Bio Works Technologies AB is generating 0.9134% of daily returns and assumes 4.5349% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than Bio, and 82% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bio Works Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Works' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bio Works Technologies AB, and traders can use it to determine the average amount a Bio Works' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BIOWKS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.53 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.91 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Bio Works is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Works by adding it to a well-diversified portfolio.
Bio Works Fundamentals Growth
Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Works, and Bio Works fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.
| Return On Equity | -0.66 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.31) % | |||
| Operating Margin | (1.27) % | |||
| Current Valuation | 635.01 M | |||
| Shares Outstanding | 34.87 M | |||
| Price To Book | 8.03 X | |||
| Price To Sales | 19.71 X | |||
| Revenue | 21.91 M | |||
| EBITDA | (8.6 M) | |||
| Cash And Equivalents | 46.35 M | |||
| Cash Per Share | 2.40 X | |||
| Book Value Per Share | 2.55 X | |||
| Cash Flow From Operations | (13.37 M) | |||
| Earnings Per Share | (0.41) X | |||
| Total Asset | 120.86 M | |||
About Bio Works Performance
By analyzing Bio Works' fundamental ratios, stakeholders can gain valuable insights into Bio Works' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio Works has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio Works has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bio-Works Technologies AB researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. Bio-Works Technologies AB founded in 2006 and is based in Uppsala, Sweden. Bio Works is traded on Stockholm Stock Exchange in Sweden.Things to note about Bio Works Technologies performance evaluation
Checking the ongoing alerts about Bio Works for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Works Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bio Works appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 21.91 M. Net Loss for the year was (12.94 M) with profit before overhead, payroll, taxes, and interest of 53.01 M. | |
| Bio Works Technologies AB has accumulated about 46.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 55.0% of the company shares are held by company insiders |
- Analyzing Bio Works' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Works' stock is overvalued or undervalued compared to its peers.
- Examining Bio Works' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio Works' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Works' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio Works' stock. These opinions can provide insight into Bio Works' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bio Stock analysis
When running Bio Works' price analysis, check to measure Bio Works' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Works is operating at the current time. Most of Bio Works' value examination focuses on studying past and present price action to predict the probability of Bio Works' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Works' price. Additionally, you may evaluate how the addition of Bio Works to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |